Skip to main content
SpringerLink
Log in

Response to “ Comment on: Alarmists at the Gates: Esophageal Adenocarcinoma After Sleeve Gastrectomy Is Not Different than with Other Bariatric/Metabolic Surgery”

  • Letter to Editor/LED Reply
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gagner M. Alarmists at the gates: esophageal adenocarcinoma after sleeve gastrectomy is not different than with other bariatric/metabolic surgeries. Obes Surg. 2022. https://doi.org/10.1007/s11695-022-05992-3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Genco et al. Comment on: Alarmists at the gates: esophageal adenocarcinoma after sleeve gastrectomy is not different than with other bariatric/metabolic surgeries. Obes Surg. 2022. https://doi.org/10.1007/s11695-022-06241-3.

  3. CastagnetoGissey L, Casella Mariolo JR, Genco A, et al. 10-year follow-up after laparoscopic sleeve gastrectomy: outcomes in a monocentric series. Surg Obes Relat Dis. 2018;14(10):1480–7.

    Article  Google Scholar 

  4. Iannelli A, Bouam S, Schneck AS, et al. Esophageal cancer in patients undergoing bariatric surgery: what is the real burden? Obes Surg. 2022;32(2):567–8.

    Article  Google Scholar 

  5. Plat VD, Kasteleijn A, Greve JWM, et al. Esophageal cancer after bariatric surgery: increasing prevalence and treatment strategies. Obes Surg. 2021;31(11):4954–62.

    Article  Google Scholar 

  6. Salminen P, Grönroos S, Helmiö M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2022. https://doi.org/10.1001/jamasurg.2022.2229.

    Article  PubMed  Google Scholar 

  7. Leslie D, Wise E, Sheka A, et al. Gastroesophageal reflux disease outcomes after vertical sleeve gastrectomy and gastric bypass. Ann Surg. 2021;274(4):646–53.

    PubMed  Google Scholar 

  8. Benvenga R, Roussel J, Cohen R, et al. Long-term endoscopic follow-up after sleeve gastrectomy. J Visc Surg. 2022;159(1):39–42.

    Article  CAS  Google Scholar 

  9. Assalia A, Gagner M, Nedelcu M, et al. Gastroesophageal reflux and laparoscopic sleeve gastrectomy: results of the first international consensus conference. Obes Surg. 2020;30(10):3695–705.

    Article  Google Scholar 

  10. Sugano K, Spechler SJ, El-Omar EM, et al. Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction. Gut. 2022:gutjnl-2022–327281. https://doi.org/10.1136/gutjnl-2022-327281.

  11. Karila-Cohen P, Pelletier AL, Saker L, et al. Staple line intrathoracic migration after sleeve gastrectomy: correlation between symptoms, CT three-dimensional stomach analysis, and 24-h pH monitoring. Obes Surg. 2022. https://doi.org/10.1007/s11695-022-06074-0.

    Article  PubMed  Google Scholar 

  12. Johari Y, Budiman K, Catchlove W, et al. Tubularized and effaced gastric cardia mimicking Barrett esophagus following sleeve gastrectomy: protocolized endoscopic and histological assessment with high-resolution manometry analysis. Ann Surg. 2022;276(1):119–27.

    Article  Google Scholar 

  13. El Khoury L, Benvenga R, Romero R, et al. Esophageal adenocarcinoma in Barrett’s esophagus after sleeve gastrectomy: case report and literature review. Int J Surg Case Rep. 2018;52:132–6.

    Article  Google Scholar 

  14. Andrew B, Alley JB, Aguilar CE, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32(2):930–6.

    Article  Google Scholar 

  15. Gorodner V, Buxhoeveden R, Clemente G, et al. Barrett’s esophagus after Roux-en-Y gastric bypass: does regression occur? Surg Endosc. 2017;31(4):1849–54.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hôpital du Sacre Coeur, Montreal, Canada

    Michel Gagner

  2. Westmount Square Surgical Center, Westmount, Canada

    Michel Gagner

Authors
  1. Michel Gagner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michel Gagner.

Ethics declarations

Ethical Statement

This article does not contain any studies with human participants or animals performed by the author.

Competing Interests

The author declares no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gagner, M. Response to “ Comment on: Alarmists at the Gates: Esophageal Adenocarcinoma After Sleeve Gastrectomy Is Not Different than with Other Bariatric/Metabolic Surgery”. OBES SURG 32, 3466–3468 (2022). https://doi.org/10.1007/s11695-022-06242-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-022-06242-2

Search

Navigation